Clinical trial

A Single Dose Escalation Study of HHT201 in Healthy Subjects

NCT06373094

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-06-01

PhasePHASE1

Study timeline

Study start (estimated)2024-06-01Date precision: day

Registry last updated2024-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

Donepezil Dihydroxynaphthalate for InjectionDRUG

Sponsors & collaborators

Shanghai Synergy Pharmaceutical Sciences Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06373094 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.